US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Rani Therapeutics Holdings

0.6012

-0.0232-3.72%

Volume:318.92K

Turnover:190.13K

Market Cap:43.21M

PE:-0.67

High:0.6244

Open:0.6244

Low:0.5773

Close:0.6244

52wk High:3.75

52wk Low:0.3870

Shares:71.87M

Float Shares:34.17M

Volume Ratio:0.52

T/O Rate:0.93%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.9027

EPS(LYR):-1.0541

ROE:-1187.52%

ROA:-93.94%

PB:-7.75

PE(LYR):-0.57

Loading ...

Overview Company News Filings

Rani Therapeutics Faces Nasdaq Compliance Challenge

Rani Therapeutics Price Target Maintained With a $9.00/Share by HC Wainwright & Co.

Rani Therapeutics Holdings: Buy Rating Backed by Strong Financial Position and Promising Clinical Trials

RANI: 2024 Financial Results

Zacks Small Cap Research

Stifel Nicolaus Reaffirms Their Buy Rating on Rani Therapeutics Holdings (RANI)

Rani Therapeutics Holdings Inc (RANI) Q4 2024 Earnings Call Highlights: Navigating Financial ...

BRIEF-Rani Therapeutics Q4 Operating Expenses USD 15.986 Million

Rani Therapeutics Holdings Inc reports results for the quarter ended December 31 - Earnings Summary

Rani Therapeutics Hldgs Q4 2024 GAAP EPS $(0.27) Misses $(0.25) Estimate

Press Release: Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update

Calendar of U.S. Earnings Expected in the Week Ahead

Calendar of U.S. Earnings Expected in the Week Ahead

BRIEF-Rani Therapeutics Announces Preclinical Data Demonstrating Bioequivalence Of RT-114, A GLP-1/GLP-2 Dual Agonist (PG-102) Delivered Orally Via The RaniPill Capsule, To Subcutaneously Administered PG-102

Rani Therapeutics Holdings Inc expected to post a loss of 25 cents a share - Earnings Preview

Rani Therapeutics Announces Preclinical Data Demonstrating Bioequivalence of RT-114, a GLP-1/GLP-2 Dual Agonist (PG-102) Delivered Orally via the RaniPill® Capsule, to Subcutaneously Administered PG-102

Rani Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results

Calendar of U.S. Earnings Expected in the Week Ahead

Calendar of U.S. Earnings Expected in the Week Ahead

Analysts Offer Insights on Healthcare Companies: COMPASS Pathways (CMPS) and Rani Therapeutics Holdings (RANI)

RANI: Impressive Bioavailability for RT-116

Zacks Small Cap Research

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/RANI/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RANI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RANI\",,,,,undefined,":{"symbol":"RANI","market":"US","secType":"STK","nameCN":"Rani Therapeutics Holdings","latestPrice":0.6012,"timestamp":1756149722986,"preClose":0.6244,"halted":0,"volume":318917,"delay":0,"floatShares":34168900,"shares":71868587,"eps":-0.902694,"marketStatus":"Trading","change":-0.0232,"latestTime":"08-25 15:29:01 EDT","open":0.6244,"high":0.6244,"low":0.5773,"amount":190127.26811511998,"amplitude":0.075432,"askPrice":0.6017,"askSize":200,"bidPrice":0.6006,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.902694,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1756152000000},"marketStatusCode":2,"adr":0,"listingDate":1627617600000,"exchange":"NASDAQ","adjPreClose":0.6244,"preHourTrading":{"tag":"盘前","latestPrice":0.6012,"preClose":0.6244,"latestTime":"09:29 EDT","volume":485,"amount":293.53281549999997,"timestamp":1756128541843},"postHourTrading":{"tag":"盘后","latestPrice":0.5999,"preClose":0.6244,"latestTime":"19:11 EDT","volume":23986,"amount":14765.0069,"timestamp":1755904300552},"volumeRatio":0.522395,"impliedVol":0.7011,"impliedVolPercentile":0.26},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RANI\",,,,,undefined,":{"symbol":"RANI","floatShares":34168900,"roa":"-93.94%","roe":"-1187.52%","lyrEps":-1.05415,"volumeRatio":0.522395,"shares":71868587,"dividePrice":0,"high":0.6244,"amplitude":0.075432,"preClose":0.6244,"low":0.5773,"week52Low":0.387,"pbRate":"-7.75","psRate":"36.01","week52High":3.75,"institutionHeld":0,"latestPrice":0.6012,"committee":-0.333333,"eps":-0.902694,"divideRate":0,"volume":318917,"delay":0,"ttmEps":-0.902694,"open":0.6244,"prevYearClose":1.37,"prevWeekClose":0.6244,"prevMonthClose":0.5359,"prevQuarterClose":0.5139,"fiveDayClose":0.5538,"twentyDayClose":0.5509,"sixtyDayClose":0.5792},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RANI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-07","symbol":"RANI","fiscalQuarterEnding":"2025/06","expectedEps":-0.19,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-0.18},{"market":"US","date":"2025-05-13","symbol":"RANI","fiscalQuarterEnding":"2025/03","expectedEps":-0.22,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":-0.22},{"market":"US","date":"2025-03-31","symbol":"RANI","fiscalQuarterEnding":"2024/12","expectedEps":-0.24,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"post","actualEps":-0.27},{"date":"2024-11-15","symbol":"RANI","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1731704400000,"name":null,"time":"Post Market","dateTimestamp":1731646800000,"actualEps":null},{"market":"US","date":"2024-08-06","symbol":"RANI","fiscalQuarterEnding":"2024/06","expectedEps":-0.29,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722916800000,"reportTimeType":"post","actualEps":-0.26}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RANI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RANI\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1722571200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RANI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RANI","date":"2025-08-22","current":-0.885164,"percent":0.854022,"low":-545.855912,"twenty":-21.233306,"median":-3.36322,"eighty":-1.650754,"high":0,"avg":-35.363221,"sd":86.527016,"marketCap":26276967},"quantilePoints":[{"date":"2021-07-30","current":0,"twenty":0,"median":0,"eighty":0,"marketCap":528090442},{"date":"2021-08-06","current":0,"twenty":0,"median":0,"eighty":0,"marketCap":566497019},{"date":"2021-08-13","current":0,"twenty":0,"median":0,"eighty":0,"marketCap":893433011},{"date":"2021-08-20","current":0,"twenty":0,"median":0,"eighty":0,"marketCap":770051880},{"date":"2021-08-27","current":0,"twenty":0,"median":0,"eighty":0,"marketCap":960164440},{"date":"2021-09-03","current":0,"twenty":0,"median":0,"eighty":0,"marketCap":950562795},{"date":"2021-09-10","current":0,"twenty":0,"median":0,"eighty":0,"marketCap":968805919},{"date":"2021-09-17","current":0,"twenty":0,"median":0,"eighty":0,"marketCap":918843431},{"date":"2021-09-24","current":0,"twenty":0,"median":0,"eighty":0,"marketCap":886010092},{"date":"2021-10-01","current":0,"twenty":0,"median":0,"eighty":0,"marketCap":888950391},{"date":"2021-10-08","current":0,"twenty":0,"median":0,"eighty":0,"marketCap":989900656},{"date":"2021-10-15","current":0,"twenty":0,"median":0,"eighty":0,"marketCap":965888214},{"date":"2021-10-22","current":0,"twenty":0,"median":0,"eighty":0,"marketCap":907572285},{"date":"2021-10-29","current":0,"twenty":0,"median":0,"eighty":0,"marketCap":1127114609},{"date":"2021-11-05","current":0,"twenty":0,"median":0,"eighty":0,"marketCap":1290301202},{"date":"2021-11-12","current":0,"twenty":0,"median":0,"eighty":0,"marketCap":1424574855},{"date":"2021-11-19","current":-531.195781,"twenty":0,"median":0,"eighty":0,"marketCap":1669017145},{"date":"2021-11-26","current":-479.573408,"twenty":0,"median":0,"eighty":0,"marketCap":1506819648},{"date":"2021-12-03","current":-339.366418,"twenty":0,"median":0,"eighty":0,"marketCap":1066289286},{"date":"2021-12-10","current":-304.119722,"twenty":0,"median":0,"eighty":0,"marketCap":955544167},{"date":"2021-12-17","current":-277.294803,"twenty":-265.753849,"median":0,"eighty":0,"marketCap":871260271},{"date":"2021-12-23","current":-290.083427,"twenty":-277.731488,"median":0,"eighty":0,"marketCap":911442129},{"date":"2021-12-31","current":-254.99269,"twenty":-285.997306,"median":0,"eighty":0,"marketCap":801187032},{"date":"2022-01-07","current":-259.04762,"twenty":-280.694706,"median":0,"eighty":0,"marketCap":813927621},{"date":"2022-01-14","current":-322.366905,"twenty":-290.800838,"median":0,"eighty":0,"marketCap":1012876817},{"date":"2022-01-21","current":-294.450275,"twenty":-301.780339,"median":0,"eighty":0,"marketCap":925162763},{"date":"2022-01-28","current":-305.835269,"twenty":-304.494023,"median":0,"eighty":0,"marketCap":960934416},{"date":"2022-02-04","current":-300.220751,"twenty":-310.07735,"median":0,"eighty":0,"marketCap":943293601},{"date":"2022-02-11","current":-257.332073,"twenty":-306.084803,"median":0,"eighty":0,"marketCap":808537372},{"date":"2022-02-18","current":-235.185919,"twenty":-305.367393,"median":0,"eighty":0,"marketCap":738954156},{"date":"2022-02-25","current":-218.654282,"twenty":-304.681174,"median":0,"eighty":0,"marketCap":687011755},{"date":"2022-03-04","current":-245.63516,"twenty":-303.183969,"median":0,"eighty":0,"marketCap":771785673},{"date":"2022-03-11","current":-230.195236,"twenty":-301.156504,"median":-195.572376,"eighty":0,"marketCap":723273431},{"date":"2022-03-18","current":-225.516471,"twenty":-300.220751,"median":-210.076546,"eighty":0,"marketCap":708572751},{"date":"2022-03-25","current":-217.094694,"twenty":-298.598779,"median":-210.466443,"eighty":0,"marketCap":682111528},{"date":"2022-04-01","current":-80.193097,"twenty":-295.479603,"median":-209.60867,"eighty":0,"marketCap":668088694},{"date":"2022-04-08","current":-75.649412,"twenty":-294.138357,"median":-203.370317,"eighty":0,"marketCap":630235251},{"date":"2022-04-14","current":-76.711572,"twenty":-292.984261,"median":-136.961665,"eighty":0,"marketCap":639084108},{"date":"2022-04-22","current":-77.419679,"twenty":-290.208194,"median":-83.202551,"eighty":0,"marketCap":644983345},{"date":"2022-04-29","current":-72.167887,"twenty":-289.615551,"median":-80.370124,"eighty":0,"marketCap":601230664},{"date":"2022-05-06","current":-69.158433,"twenty":-287.494511,"median":-79.484991,"eighty":0,"marketCap":576158903},{"date":"2022-05-13","current":-37.15566,"twenty":-286.309223,"median":-77.62621,"eighty":0,"marketCap":540763476},{"date":"2022-05-20","current":-38.506775,"twenty":-285.030361,"median":-77.301661,"eighty":0,"marketCap":560427602},{"date":"2022-05-27","current":-38.236552,"twenty":-282.223102,"median":-76.741077,"eighty":0,"marketCap":556494777},{"date":"2022-06-03","current":-35.466766,"twenty":-279.478227,"median":-76.416528,"eighty":0,"marketCap":516183318},{"date":"2022-06-10","current":-31.7512,"twenty":-279.478227,"median":-75.649412,"eighty":0,"marketCap":462106970},{"date":"2022-06-17","current":-38.000107,"twenty":-277.294803,"median":-72.285904,"eighty":0,"marketCap":553053555},{"date":"2022-06-24","current":-41.783229,"twenty":-275.797598,"median":-70.66316,"eighty":0,"marketCap":608113108},{"date":"2022-07-01","current":-35.905879,"twenty":-270.682149,"median":-68.332308,"eighty":0,"marketCap":522574159},{"date":"2022-07-08","current":-41.884562,"twenty":-267.53178,"median":-62.431418,"eighty":0,"marketCap":609587918},{"date":"2022-07-15","current":-41.006338,"twenty":-265.941,"median":-41.935229,"eighty":0,"marketCap":596806236},{"date":"2022-07-22","current":-40.567225,"twenty":-265.473123,"median":-41.614339,"eighty":0,"marketCap":590415395},{"date":"2022-07-29","current":-38.000107,"twenty":-265.192398,"median":-41.073893,"eighty":0,"marketCap":553053555},{"date":"2022-08-05","current":-40.533447,"twenty":-264.662138,"median":-41.073893,"eighty":0,"marketCap":589923792},{"date":"2022-08-12","current":-25.089877,"twenty":-264.256645,"median":-40.97256,"eighty":0,"marketCap":556443293},{"date":"2022-08-19","current":-24.424951,"twenty":-261.854878,"median":-40.769892,"eighty":0,"marketCap":541696563},{"date":"2022-08-26","current":-20.83435,"twenty":-260.29529,"median":-40.550336,"eighty":0,"marketCap":462064219},{"date":"2022-09-02","current":-21.344127,"twenty":-259.546688,"median":-40.195669,"eighty":0,"marketCap":473370045},{"date":"2022-09-09","current":-21.920396,"twenty":-258.361401,"median":-39.553889,"eighty":0,"marketCap":486150545},{"date":"2022-09-16","current":-19.659647,"twenty":-257.269689,"median":-38.945887,"eighty":0,"marketCap":436011662},{"date":"2022-09-23","current":-20.346738,"twenty":-256.302744,"median":-38.506775,"eighty":0,"marketCap":451249950},{"date":"2022-09-30","current":-21.233306,"twenty":-254.805539,"median":-38.185885,"eighty":0,"marketCap":470912257},{"date":"2022-10-07","current":-15.758748,"twenty":-254.337663,"median":-38.000107,"eighty":0,"marketCap":349497510},{"date":"2022-10-14","current":-15.692255,"twenty":-253.433102,"median":-37.425883,"eighty":0,"marketCap":348022837},{"date":"2022-10-21","current":-15.692255,"twenty":-251.748747,"median":-37.15566,"eighty":0,"marketCap":348022837},{"date":"2022-10-28","current":-13.497999,"twenty":-249.877241,"median":-37.15566,"eighty":0,"marketCap":299358627},{"date":"2022-11-04","current":-14.539717,"twenty":-247.880967,"median":-36.784103,"eighty":0,"marketCap":322461838},{"date":"2022-11-11","current":-11.868678,"twenty":-246.258995,"median":-36.142324,"eighty":0,"marketCap":320347490},{"date":"2022-11-18","current":-13.514566,"twenty":-245.728735,"median":-35.669434,"eighty":0,"marketCap":364771641},{"date":"2022-11-25","current":-14.630112,"twenty":-244.886558,"median":-35.500544,"eighty":0,"marketCap":394881344},{"date":"2022-12-02","current":-14.611824,"twenty":-241.860956,"median":-34.875654,"eighty":0,"marketCap":394387742},{"date":"2022-12-09","current":-14.575249,"twenty":-240.426135,"median":-33.777873,"eighty":0,"marketCap":393400538},{"date":"2022-12-16","current":-13.09395,"twenty":-235.123535,"median":-32.460535,"eighty":0,"marketCap":353418802},{"date":"2022-12-23","current":-11.064022,"twenty":-234.437316,"median":-31.7512,"eighty":0,"marketCap":298629016},{"date":"2022-12-30","current":-10.789707,"twenty":-232.690577,"median":-29.825862,"eighty":0,"marketCap":291224991},{"date":"2023-01-06","current":-11.886966,"twenty":-230.694304,"median":-27.022298,"eighty":0,"marketCap":320841092},{"date":"2023-01-13","current":-11.960116,"twenty":-226.452224,"median":-25.222862,"eighty":0,"marketCap":322815498},{"date":"2023-01-20","current":-11.137173,"twenty":-223.551389,"median":-24.563478,"eighty":0,"marketCap":300603423},{"date":"2023-01-27","current":-10.423955,"twenty":-221.773459,"median":-24.402787,"eighty":0,"marketCap":281352957},{"date":"2023-02-03","current":-10.14964,"twenty":-220.712938,"median":-22.452337,"eighty":0,"marketCap":273948932},{"date":"2023-02-10","current":-10.84457,"twenty":-219.278117,"median":-22.164202,"eighty":-6.023948,"marketCap":292705796},{"date":"2023-02-17","current":-10.881146,"twenty":-218.560707,"median":-21.953643,"eighty":-9.374244,"marketCap":293692999},{"date":"2023-02-24","current":-11.411487,"twenty":-217.936871,"median":-21.521441,"eighty":-9.644901,"marketCap":308007448},{"date":"2023-03-03","current":-11.521213,"twenty":-216.907543,"median":-21.233306,"eighty":-10.054544,"marketCap":310969058},{"date":"2023-03-10","current":-11.77724,"twenty":-216.127749,"median":-21.111403,"eighty":-10.076489,"marketCap":317879481},{"date":"2023-03-17","current":-11.604167,"twenty":-215.067229,"median":-20.812186,"eighty":-10.105749,"marketCap":313208083},{"date":"2023-03-24","current":-8.739269,"twenty":-213.102148,"median":-20.62379,"eighty":-10.054544,"marketCap":267316772},{"date":"2023-03-31","current":-8.335421,"twenty":-210.544423,"median":-20.501887,"eighty":-9.11487,"marketCap":254963871},{"date":"2023-04-06","current":-8.480807,"twenty":-209.982971,"median":-20.346738,"eighty":-8.820039,"marketCap":259410915},{"date":"2023-04-14","current":-8.705107,"twenty":-209.60867,"median":-20.191588,"eighty":-8.739269,"marketCap":266271828},{"date":"2023-04-21","current":-8.543303,"twenty":-208.049082,"median":-19.848043,"eighty":-8.640386,"marketCap":261322538},{"date":"2023-04-28","current":-7.16796,"twenty":-206.021617,"median":-19.659647,"eighty":-8.480807,"marketCap":219253569},{"date":"2023-05-05","current":-7.653375,"twenty":-201.779537,"median":-19.172035,"eighty":-8.306344,"marketCap":234101440},{"date":"2023-05-12","current":-5.926389,"twenty":-192.484391,"median":-18.030579,"eighty":-7.692209,"marketCap":194012187},{"date":"2023-05-19","current":-6.63692,"twenty":-105.355295,"median":-17.132928,"eighty":-7.604834,"marketCap":217272865},{"date":"2023-05-26","current":-6.213609,"twenty":-83.615614,"median":-15.725502,"eighty":-7.148543,"marketCap":203414914},{"date":"2023-06-02","current":-6.470619,"twenty":-83.379578,"median":-15.692255,"eighty":-6.924602,"marketCap":211828670},{"date":"2023-06-09","current":-7.483544,"twenty":-82.907331,"median":-15.526024,"eighty":-6.924602,"marketCap":244988766},{"date":"2023-06-16","current":-6.697394,"twenty":-82.081031,"median":-15.239897,"eighty":-6.924385,"marketCap":219252572},{"date":"2023-06-23","current":-6.500856,"twenty":-80.547151,"median":-15.078159,"eighty":-6.72763,"marketCap":212818524},{"date":"2023-06-30","current":-6.213609,"twenty":-80.263908,"median":-14.986721,"eighty":-6.664133,"marketCap":203414914},{"date":"2023-07-07","current":-6.349673,"twenty":-79.874449,"median":-14.812988,"eighty":-6.543187,"marketCap":207869256},{"date":"2023-07-14","current":-6.576447,"twenty":-79.555801,"median":-14.666687,"eighty":-6.509939,"marketCap":215293158},{"date":"2023-07-21","current":-6.455501,"twenty":-79.190498,"median":-14.620968,"eighty":-6.470619,"marketCap":211333743},{"date":"2023-07-28","current":-6.319437,"twenty":-78.261907,"median":-14.539717,"eighty":-6.455501,"marketCap":206879402},{"date":"2023-08-04","current":-6.500856,"twenty":-77.596706,"median":-14.456379,"eighty":-6.455501,"marketCap":212818524},{"date":"2023-08-11","current":-6.395028,"twenty":-77.443283,"median":-14.428896,"eighty":-6.449454,"marketCap":209354036},{"date":"2023-08-18","current":-5.78479,"twenty":-77.348868,"median":-14.045177,"eighty":-6.37991,"marketCap":199089346},{"date":"2023-08-25","current":-5.712661,"twenty":-76.983013,"median":-13.808298,"eighty":-6.333923,"marketCap":196606935},{"date":"2023-09-01","current":-5.481846,"twenty":-76.770581,"median":-13.706586,"eighty":-6.261987,"marketCap":188663220},{"date":"2023-09-08","current":-5.409717,"twenty":-76.746977,"median":-13.55341,"eighty":-6.204538,"marketCap":186180810},{"date":"2023-09-15","current":-4.212366,"twenty":-76.711572,"median":-13.497999,"eighty":-6.170668,"marketCap":144972790},{"date":"2023-09-22","current":-4.27007,"twenty":-76.593554,"median":-13.365014,"eighty":-6.155852,"marketCap":146958719},{"date":"2023-09-29","current":-3.822866,"twenty":-76.074276,"median":-12.87595,"eighty":-6.01272,"marketCap":131567772},{"date":"2023-10-06","current":-2.870756,"twenty":-75.885447,"median":-12.700766,"eighty":-5.78479,"marketCap":98799949},{"date":"2023-10-13","current":-2.870756,"twenty":-75.649412,"median":-12.490458,"eighty":-5.626105,"marketCap":98799949},{"date":"2023-10-20","current":-2.914034,"twenty":-75.413376,"median":-12.271006,"eighty":-5.493387,"marketCap":100289396},{"date":"2023-10-27","current":-2.870756,"twenty":-74.764278,"median":-12.197856,"eighty":-5.481846,"marketCap":98799949},{"date":"2023-11-02","current":-2.755349,"twenty":-72.994011,"median":-12.179568,"eighty":-5.476076,"marketCap":94828092},{"date":"2023-11-10","current":-2.691836,"twenty":-72.215094,"median":-11.905253,"eighty":-4.870187,"marketCap":95985492},{"date":"2023-11-17","current":-2.776182,"twenty":-70.987709,"median":-11.877822,"eighty":-4.246988,"marketCap":98993085},{"date":"2023-11-24","current":-2.818245,"twenty":-70.657259,"median":-11.786384,"eighty":-4.004633,"marketCap":100492981},{"date":"2023-12-01","current":-1.437056,"twenty":-69.748522,"median":-11.622528,"eighty":-3.8748,"marketCap":51242526},{"date":"2023-12-08","current":-1.8943,"twenty":-68.662758,"median":-11.608409,"eighty":-2.965968,"marketCap":67546967},{"date":"2023-12-15","current":-2.141068,"twenty":-66.207988,"median":-11.521213,"eighty":-2.870756,"marketCap":76346188},{"date":"2023-12-22","current":-2.278967,"twenty":-63.37556,"median":-11.484637,"eighty":-2.85633,"marketCap":81263400},{"date":"2023-12-29","current":-2.431382,"twenty":-62.266193,"median":-11.411487,"eighty":-2.834194,"marketCap":86698214},{"date":"2024-01-05","current":-2.278967,"twenty":-61.770518,"median":-11.365768,"eighty":-2.827479,"marketCap":81263400},{"date":"2024-01-12","current":-2.40235,"twenty":-45.909775,"median":-11.338337,"eighty":-2.818245,"marketCap":85663011},{"date":"2024-01-19","current":-2.525734,"twenty":-41.925096,"median":-11.246898,"eighty":-2.795257,"marketCap":90062622},{"date":"2024-01-26","current":-2.656375,"twenty":-41.884562,"median":-11.064022,"eighty":-2.773242,"marketCap":94721034},{"date":"2024-02-02","current":-2.50396,"twenty":-41.844028,"median":-11.064022,"eighty":-2.717205,"marketCap":89286220},{"date":"2024-02-09","current":-2.754356,"twenty":-41.79674,"median":-10.930408,"eighty":-2.686361,"marketCap":98214842},{"date":"2024-02-16","current":-2.467671,"twenty":-41.681895,"median":-10.881146,"eighty":-2.663633,"marketCap":87992217},{"date":"2024-02-23","current":-2.366061,"twenty":-41.452205,"median":-10.807995,"eighty":-2.601216,"marketCap":84369008},{"date":"2024-03-01","current":-2.714438,"twenty":-41.181983,"median":-10.789707,"eighty":-2.532992,"marketCap":96791439},{"date":"2024-03-08","current":-2.663633,"twenty":-41.114427,"median":-10.698269,"eighty":-2.556217,"marketCap":94979834},{"date":"2024-03-15","current":-2.264451,"twenty":-41.046871,"median":-10.524536,"eighty":-2.517024,"marketCap":80745799},{"date":"2024-03-22","current":-2.759701,"twenty":-41.006338,"median":-10.241078,"eighty":-2.506863,"marketCap":93747052},{"date":"2024-03-28","current":-2.322749,"twenty":-40.992827,"median":-10.186215,"eighty":-2.50396,"marketCap":78903769},{"date":"2024-04-05","current":-2.882355,"twenty":-40.925271,"median":-10.158784,"eighty":-2.497175,"marketCap":97913588},{"date":"2024-04-12","current":-3.426629,"twenty":-40.850959,"median":-10.076489,"eighty":-2.500042,"marketCap":116402590},{"date":"2024-04-19","current":-4.683728,"twenty":-40.736114,"median":-9.49657,"eighty":-2.50396,"marketCap":159106245},{"date":"2024-04-26","current":-5.078555,"twenty":-40.594247,"median":-9.013886,"eighty":-2.50396,"marketCap":172518507},{"date":"2024-05-03","current":-4.931463,"twenty":-40.560469,"median":-8.964723,"eighty":-2.50396,"marketCap":167521782},{"date":"2024-05-10","current":-5.389927,"twenty":-40.533447,"median":-8.820039,"eighty":-2.505412,"marketCap":178304189},{"date":"2024-05-17","current":-4.340561,"twenty":-40.465891,"median":-8.755423,"eighty":-2.514121,"marketCap":143590099},{"date":"2024-05-24","current":-3.919225,"twenty":-40.128113,"median":-8.640386,"eighty":-2.527186,"marketCap":129651866},{"date":"2024-05-31","current":-4.373244,"twenty":-39.85789,"median":-8.543303,"eighty":-2.532992,"marketCap":144671290},{"date":"2024-06-07","current":-3.490644,"twenty":-39.553889,"median":-8.479694,"eighty":-2.532992,"marketCap":115473993},{"date":"2024-06-14","current":-3.204395,"twenty":-39.351222,"median":-8.335421,"eighty":-2.537392,"marketCap":106004600},{"date":"2024-06-21","current":-3.299811,"twenty":-39.108021,"median":-7.947727,"eighty":-2.56871,"marketCap":109161064},{"date":"2024-06-28","current":-3.021514,"twenty":-38.885087,"median":-7.677646,"eighty":-2.588152,"marketCap":99954709},{"date":"2024-07-05","current":-2.973806,"twenty":-38.641887,"median":-7.620311,"eighty":-2.59541,"marketCap":98376477},{"date":"2024-07-12","current":-2.942001,"twenty":-38.506775,"median":-7.604834,"eighty":-2.602667,"marketCap":97324322},{"date":"2024-07-19","current":-2.449017,"twenty":-38.486508,"median":-7.468426,"eighty":-2.602667,"marketCap":81015922},{"date":"2024-07-26","current":-2.577744,"twenty":-38.33113,"median":-7.347479,"eighty":-2.577262,"marketCap":85274342},{"date":"2024-08-02","current":-2.349002,"twenty":-38.175752,"median":-7.203855,"eighty":-2.532992,"marketCap":77707335},{"date":"2024-08-09","current":-2.164456,"twenty":-38.054151,"median":-7.070877,"eighty":-2.509676,"marketCap":66195544},{"date":"2024-08-16","current":-2.672049,"twenty":-38.000107,"median":-6.92471,"eighty":-2.509676,"marketCap":81719278},{"date":"2024-08-23","current":-2.940212,"twenty":-37.85824,"median":-6.742748,"eighty":-2.519461,"marketCap":89920496},{"date":"2024-08-30","current":-3.064716,"twenty":-37.662328,"median":-6.704953,"eighty":-2.525423,"marketCap":93728204},{"date":"2024-09-06","current":-2.509236,"twenty":-37.459661,"median":-6.682275,"eighty":-2.525268,"marketCap":76739967},{"date":"2024-09-13","current":-2.269805,"twenty":-37.256994,"median":-6.652039,"eighty":-2.509236,"marketCap":69417451},{"date":"2024-09-20","current":-2.241073,"twenty":-37.21646,"median":-6.64448,"eighty":-2.50396,"marketCap":68538749},{"date":"2024-09-27","current":-2.068683,"twenty":-37.15566,"median":-6.561329,"eighty":-2.494331,"marketCap":63266538},{"date":"2024-10-04","current":-2.241073,"twenty":-37.15566,"median":-6.515974,"eighty":-2.489445,"marketCap":68538749},{"date":"2024-10-11","current":-1.934602,"twenty":-37.15566,"median":-6.500886,"eighty":-2.472562,"marketCap":59165929},{"date":"2024-10-18","current":-2.829591,"twenty":-37.007037,"median":-6.500856,"eighty":-2.472562,"marketCap":86537371},{"date":"2024-10-25","current":-2.470613,"twenty":-36.784103,"median":-6.470619,"eighty":-2.474327,"marketCap":75558749},{"date":"2024-11-01","current":-2.438938,"twenty":-36.689525,"median":-6.46306,"eighty":-2.467671,"marketCap":74590047},{"date":"2024-11-08","current":-2.54452,"twenty":-36.480102,"median":-6.455501,"eighty":-2.467671,"marketCap":77819054},{"date":"2024-11-15","current":-2.684412,"twenty":-36.189613,"median":-6.410146,"eighty":-2.468848,"marketCap":75617202},{"date":"2024-11-22","current":-2.459726,"twenty":-35.865345,"median":-6.37991,"eighty":-2.460413,"marketCap":69288009},{"date":"2024-11-29","current":-2.388772,"twenty":-35.777523,"median":-6.349673,"eighty":-2.459726,"marketCap":67289316},{"date":"2024-12-06","current":-2.282341,"twenty":-35.642412,"median":-6.326206,"eighty":-2.44033,"marketCap":64291277},{"date":"2024-12-13","current":-1.96305,"twenty":-35.527566,"median":-6.274082,"eighty":-2.430406,"marketCap":55297161},{"date":"2024-12-20","current":-1.655585,"twenty":-35.493788,"median":-6.213609,"eighty":-2.419082,"marketCap":46636160},{"date":"2024-12-27","current":-1.679236,"twenty":-35.466766,"median":-6.198491,"eighty":-2.412423,"marketCap":47302391},{"date":"2025-01-03","current":-1.803405,"twenty":-35.007388,"median":-6.178831,"eighty":-2.40235,"marketCap":50800103},{"date":"2025-01-10","current":-1.4782,"twenty":-34.872276,"median":-6.168254,"eighty":-2.394779,"marketCap":41639428},{"date":"2025-01-17","current":-1.549154,"twenty":-34.595297,"median":-6.153136,"eighty":-2.386331,"marketCap":43638121},{"date":"2025-01-24","current":-1.773841,"twenty":-34.16294,"median":-6.077572,"eighty":-2.368964,"marketCap":49967314},{"date":"2025-01-31","current":-1.643759,"twenty":-33.764362,"median":-6.013845,"eighty":-2.350719,"marketCap":46303044},{"date":"2025-02-07","current":-1.797492,"twenty":-33.365783,"median":-5.93051,"eighty":-2.311996,"marketCap":50633545},{"date":"2025-02-14","current":-2.187737,"twenty":-32.528091,"median":-5.849707,"eighty":-2.292791,"marketCap":61626354},{"date":"2025-02-21","current":-1.96305,"twenty":-32.116001,"median":-5.705448,"eighty":-2.282341,"marketCap":55297161},{"date":"2025-02-28","current":-1.809317,"twenty":-32.021423,"median":-5.654957,"eighty":-2.278967,"marketCap":50966660},{"date":"2025-03-07","current":-1.844794,"twenty":-31.697155,"median":-5.546763,"eighty":-2.264451,"marketCap":51966007},{"date":"2025-03-14","current":-1.785666,"twenty":-31.149954,"median":-5.496272,"eighty":-2.242231,"marketCap":50300429},{"date":"2025-03-21","current":-1.832969,"twenty":-29.339461,"median":-5.481846,"eighty":-2.212342,"marketCap":51632891},{"date":"2025-03-28","current":-1.608282,"twenty":-27.319544,"median":-5.473381,"eighty":-2.200203,"marketCap":45303698},{"date":"2025-04-04","current":-1.350753,"twenty":-26.915083,"median":-5.410583,"eighty":-2.178608,"marketCap":40546890},{"date":"2025-04-11","current":-1.328426,"twenty":-26.260147,"median":-5.366439,"eighty":-2.164456,"marketCap":39876694},{"date":"2025-04-17","current":-1.3061,"twenty":-25.355847,"median":-5.186939,"eighty":-2.141068,"marketCap":39206497},{"date":"2025-04-25","current":-1.250283,"twenty":-25.089877,"median":-5.167585,"eighty":-2.087838,"marketCap":37531006},{"date":"2025-05-02","current":-1.20563,"twenty":-24.613347,"median":-5.016289,"eighty":-2.068489,"marketCap":36190613},{"date":"2025-05-09","current":-0.814917,"twenty":-24.513608,"median":-4.935334,"eighty":-2.045829,"marketCap":24462173},{"date":"2025-05-16","current":-0.720373,"twenty":-24.424951,"median":-4.857294,"eighty":-1.972911,"marketCap":21466395},{"date":"2025-05-23","current":-0.728807,"twenty":-24.402787,"median":-4.519067,"eighty":-1.934602,"marketCap":21717718},{"date":"2025-05-30","current":-0.652501,"twenty":-24.030429,"median":-4.407713,"eighty":-1.863715,"marketCap":19443890},{"date":"2025-06-06","current":-0.595836,"twenty":-22.944382,"median":-4.373244,"eighty":-1.827413,"marketCap":17755306},{"date":"2025-06-13","current":-0.631435,"twenty":-22.306053,"median":-4.262857,"eighty":-1.809317,"marketCap":18816126},{"date":"2025-06-20","current":-0.572291,"twenty":-22.181934,"median":-4.192991,"eighty":-1.797492,"marketCap":17053688},{"date":"2025-06-27","current":-0.58243,"twenty":-22.164202,"median":-4.149767,"eighty":-1.773841,"marketCap":17355820},{"date":"2025-07-03","current":-0.603158,"twenty":-22.137605,"median":-4.086169,"eighty":-1.765576,"marketCap":17973513},{"date":"2025-07-11","current":-0.743865,"twenty":-22.053382,"median":-4.024829,"eighty":-1.750189,"marketCap":22166438},{"date":"2025-07-18","current":-0.548945,"twenty":-21.960292,"median":-3.995977,"eighty":-1.734816,"marketCap":16358000},{"date":"2025-07-25","current":-0.733469,"twenty":-21.831739,"median":-3.964189,"eighty":-1.726538,"marketCap":21856641},{"date":"2025-08-01","current":-0.783937,"twenty":-21.556903,"median":-3.909422,"eighty":-1.691061,"marketCap":23360539},{"date":"2025-08-08","current":-0.779695,"twenty":-21.335261,"median":-3.717257,"eighty":-1.679236,"marketCap":23234124},{"date":"2025-08-15","current":-0.898394,"twenty":-21.2865,"median":-3.601963,"eighty":-1.67214,"marketCap":26669733},{"date":"2025-08-22","current":-0.885164,"twenty":-21.233306,"median":-3.36322,"eighty":-1.650754,"marketCap":26276967}],"updateTime":1756110549194},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RANI\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2533696433","title":"Rani Therapeutics Faces Nasdaq Compliance Challenge","url":"https://stock-news.laohu8.com/highlight/detail?id=2533696433","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533696433?lang=en_us&edition=fundamental","pubTime":"2025-05-07 06:04","pubTimestamp":1746569083,"startTime":"0","endTime":"0","summary":"Rani Therapeutics Holdings ( ($RANI) ) has provided an update. On May 1, 2025, Rani Therapeutics Holdings, Inc. received a compliance deficiency no...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/rani-therapeutics-faces-nasdaq-compliance-challenge?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/rani-therapeutics-faces-nasdaq-compliance-challenge?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","IE00B64PRP62.GBP","BK4139","BK4007","LU2095319765.USD",".IXIC","BK4585","QID","TSYW.SI","QLD","IE00BKPKM429.USD","IE00BGHQF748.EUR","NVIW.SI","PSQ","BK4539","USAW.SI","USJW.SI","LU2210149790.SGD","NDAQ","BK4112","SQQQ","RANI","MNQmain","BK4588","TQQQ","IE00B3QW5Z07.USD","LU2210150020.SGD","NQmain"],"gpt_icon":0},{"id":"2524230649","title":"Rani Therapeutics Price Target Maintained With a $9.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2524230649","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524230649?lang=en_us&edition=fundamental","pubTime":"2025-04-03 19:07","pubTimestamp":1743678420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RANI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 03, 2025 07:07 ET (11:07 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RANI","LENZ"],"gpt_icon":0},{"id":"2524234962","title":"Rani Therapeutics Holdings: Buy Rating Backed by Strong Financial Position and Promising Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2524234962","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524234962?lang=en_us&edition=fundamental","pubTime":"2025-04-03 18:17","pubTimestamp":1743675423,"startTime":"0","endTime":"0","summary":"Analyst Mitchell Kapoor of H.C. Wainwright reiterated a Buy rating on Rani Therapeutics Holdings (RANI – Research Report), retaining the price targ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/rani-therapeutics-holdings-buy-rating-backed-by-strong-financial-position-and-promising-clinical-trials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/rani-therapeutics-holdings-buy-rating-backed-by-strong-financial-position-and-promising-clinical-trials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RANI"],"gpt_icon":0},{"id":"2524126229","title":"RANI: 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2524126229","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524126229?lang=en_us&edition=fundamental","pubTime":"2025-04-01 23:31","pubTimestamp":1743521460,"startTime":"0","endTime":"0","summary":"On March 31st, Rani Therapeutics Holdings, Inc.  reported 2024 results. Since the third quarter report, Rani has participated in multiple investor conferences, raised an additional $10 million and reported glucagon-like peptide-1 receptor  incretin triagonist data. Most importantly, Rani’s lead program, RT-114, produced favorable preclinical data demonstrating superior bioavailability compared to the underlying molecule’s subcutaneous results. In parallel, partner ProGen provided an update on their Phase I trial for PG-102 which is in the vanguard for the GLP-1/GLP-2 dual agonist program. The other significant area of interest is an anticipated deal with an established biopharmaceutical company which may include upfronts, milestones and royalties for Rani. In this vein, Rani conducted testing on behalf of an unnamed but significant biopharma, receiving $1.0 million in contract revenue and germinating a prospect in the process.Research and development expenses totaled $26.7 million, dow","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/rani-2024-financial-results-153100664.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE000M9KFDE8.USD","LU2129689514.USD","BK4504","BK4533","LU0096364046.USD","LU0098860793.USD","LU1914381329.SGD","BK4541","BK4567","SG9999002224.SGD","BK4539","SG9999014567.USD","LU0124676726.USD","LU0061475181.USD","LU1066053197.SGD","IE00BLSP4452.SGD","LU0823414478.USD","BK4550","LU0640476718.USD","RANI","LU2129689431.USD","LU1868837136.USD","LU1868837300.USD","SG9999015341.SGD","BK4559","LU1066051498.USD","PLUG","LU1720051017.SGD","LU0234570918.USD","SG9999014542.SGD","LU2552382058.USD","PG","LU0689626769.HKD","BK4588","LU1430594728.SGD","BK4534","SG9999002232.USD","LU2242652126.USD","LU2129689605.HKD","SG9999001440.SGD","BK4018","BK4585","LU0237698245.USD","LU0323591593.USD","LU1162221912.USD","LU0094547139.USD","SG9999014575.USD","LU2552382132.HKD","IE00B3T34201.USD","IE00BWXC8680.SGD"],"gpt_icon":0},{"id":"2524118633","title":"Stifel Nicolaus Reaffirms Their Buy Rating on Rani Therapeutics Holdings (RANI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2524118633","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524118633?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:56","pubTimestamp":1743508601,"startTime":"0","endTime":"0","summary":"In a report released today, Annabel Samimy from Stifel Nicolaus maintained a Buy rating on Rani Therapeutics Holdings (RANI – Research Report), wit...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-reaffirms-their-buy-rating-on-rani-therapeutics-holdings-rani-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-reaffirms-their-buy-rating-on-rani-therapeutics-holdings-rani-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RANI","SF"],"gpt_icon":0},{"id":"2524821154","title":"Rani Therapeutics Holdings Inc (RANI) Q4 2024 Earnings Call Highlights: Navigating Financial ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2524821154","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524821154?lang=en_us&edition=fundamental","pubTime":"2025-04-01 15:05","pubTimestamp":1743491110,"startTime":"0","endTime":"0","summary":"Cash, Cash Equivalents, and Marketable Securities: $27.6 million as of December 31, 2024, compared to $48.5 million as of December 31, 2023.Contract Revenue: Approximately $1 million for the fourth quarter and full year 2024, with no contract revenue for the same period in 2023.Research and Development Expenses: $6.8 million for Q4 2024 and $26.7 million for the full year 2024, compared to $7.6 million and $39.6 million for the same periods in 2023.General and Administrative Expenses: $5.5 million for Q4 2024 and $23.9 million for the full year 2024, compared to $5.8 million and $26.5 million for the same periods in 2023.Impairment Loss: $3.7 million related to certain manufacturing property and equipment in 2024, with no such losses in 2023.Net Loss: $15.7 million for Q4 2024 and $56.6 million for the full year 2024, compared to $14.1 million and $67.9 million for the same periods in 2023.Stock-Based Compensation Expense: $4 million for Q4 2024 and $16 million for the full year 2024, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/rani-therapeutics-holdings-inc-rani-070510778.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RANI"],"gpt_icon":0},{"id":"2524906481","title":"BRIEF-Rani Therapeutics Q4 Operating Expenses USD 15.986 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2524906481","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524906481?lang=en_us&edition=fundamental","pubTime":"2025-04-01 06:43","pubTimestamp":1743461009,"startTime":"0","endTime":"0","summary":"BRIEF-Rani Therapeutics Q4 Operating Expenses USD 15.986 MillionMarch 31 (Reuters) - Rani Therapeutics Holdings Inc RANI.O:RANI THERAPEUTICS Q4 OPERATING EXPENSES USD 15.986 MILLIONRANI THERAPEUTICS Q","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nPLX769C86:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RANI"],"gpt_icon":1},{"id":"2524970922","title":"Rani Therapeutics Holdings Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2524970922","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524970922?lang=en_us&edition=fundamental","pubTime":"2025-04-01 05:00","pubTimestamp":1743454857,"startTime":"0","endTime":"0","summary":"Rani Therapeutics Holdings Inc reports results for the quarter ended December 31 - Earnings SummaryRani Therapeutics Holdings Inc RANI.OQ reported a quarterly adjusted loss of 27 cents per share for t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nL5N3QE1OQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RANI"],"gpt_icon":0},{"id":"2524974956","title":"Rani Therapeutics Hldgs Q4 2024 GAAP EPS $(0.27) Misses $(0.25) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2524974956","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524974956?lang=en_us&edition=fundamental","pubTime":"2025-04-01 04:07","pubTimestamp":1743451649,"startTime":"0","endTime":"0","summary":"Rani Therapeutics Hldgs (NASDAQ:RANI) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.25) by 8 percent. This is unchanged from the same period last year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44570896/rani-therapeutics-hldgs-q4-2024-gaap-eps-0-27-misses-0-25-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","RANI"],"gpt_icon":0},{"id":"2524974695","title":"Press Release: Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2524974695","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524974695?lang=en_us&edition=fundamental","pubTime":"2025-04-01 04:05","pubTimestamp":1743451500,"startTime":"0","endTime":"0","summary":"- Announced preclinical data demonstrating the bioequivalence of RT-114, a GLP-1/GLP-2 dual agonist  delivered orally via the RaniPill capsule, to subcutaneous administration of PG-102 -. - Preclinical data of four incretin-based molecules underscores the RaniPill platform's potential to facilitate the oral delivery of a diverse array of obesity treatments -. - Phase 1 study for RT-114 for the treatment of obesity, expected to initiate in mid-2025 -. - Conference call today at 4:30 p.m. ET / 1:30 p.m. PT -. SAN JOSE, Calif., March 31, 2025  -- Rani Therapeutics Holdings, Inc.  , a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today reported financial results for the quarter and full year ended December 31, 2024 and provided a corporate update.-- Positive topline results from phase 1 study of an oral anti-interleukin. 12/23 antibody . In February 2024, Rani announced RT-111 achieved. high bioavailability and was well tolerated, with no serio","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0098860793.USD","PG","IE00BLSP4239.USD","LU1162221912.USD","RANI","IE00BBT3K403.USD","BK4567","BK4018","LU1868836757.USD","BK4585","BK4533","LU2242652126.USD","LU0061475181.USD","LU2129689431.USD","BK4558","LU0640476718.USD","LU2552382132.HKD","LU1868836591.USD","IE00B1XK9C88.USD","LU2552382058.USD","R","BK4534","BK4007","SG9999014567.USD","LU0689626769.HKD","LU1066053197.SGD","BK4139","LU1868837136.USD","SG9999015341.SGD","LU0096364046.USD","IE00BWXC8680.SGD","LU1929549753.HKD","SG9999002232.USD","SG9999014542.SGD","LU2552382215.SGD","LENZ","BK4550","LU2129689605.HKD","BK4581","SG9999014575.USD","SG9999002224.SGD","BK4022","SG9999001440.SGD","BK4559","LU0323591593.USD","LU1868837300.USD","LU0237698245.USD","SG9999015358.SGD","LU2129689514.USD","IE000M9KFDE8.USD"],"gpt_icon":0},{"id":"2523915166","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2523915166","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523915166?lang=en_us&edition=fundamental","pubTime":"2025-03-31 18:00","pubTimestamp":1743415200,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RANI","PVH","BHST","BLRX","BK4141","BK4584","FTCI","PENG","SLP","TTGT","BK4167","PROK","LW","APOG","LNN","SPIR","SGML","FC","LPRO","BK4524","AMC","DARE","LU0054578231.USD","BK4086","UNF","CUK","RDUS","CAG","ANGO","REKR","LOAR","RH","GWH","BK4023","PVLA","MSM","SPWH","BK4007","NNOX","LNZA","CELC","WPRT","BK4178","OMER","PRGS","NCNO","BW","AYI","BK4200"],"gpt_icon":0},{"id":"2522329609","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2522329609","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522329609?lang=en_us&edition=fundamental","pubTime":"2025-03-27 18:00","pubTimestamp":1743069600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·INmune Bio Inc.                                 4Q      (.55)  4:05 PM. ·TD SYNNEX Corp                                   1Q      2.91   8:05 AM","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","GWH","EDAP","ATAI","FBIO","SKYH","WBA","PVLA","KYTX","ANGO","CLSD","CELC","PRGS","PVH","BW","INMB","REKR","RANI","BLRX","INR","WKSP","ADCT","AFMD","FC","NUTX","IKT","GEVO","SDST","BRZE","LNZA","SGML","SLRN","BCAB","CRDL","FEMY","PENG","WGO","NNOX","RLMD","FTCI","GOVX","BHST","UNCY","LULU","MDAI","TLSI","TSAT","SPWH","NCNO","DARE"],"gpt_icon":0},{"id":"2522215330","title":"BRIEF-Rani Therapeutics Announces Preclinical Data Demonstrating Bioequivalence Of RT-114, A GLP-1/GLP-2 Dual Agonist (PG-102) Delivered Orally Via The RaniPill Capsule, To Subcutaneously Administered PG-102","url":"https://stock-news.laohu8.com/highlight/detail?id=2522215330","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522215330?lang=en_us&edition=fundamental","pubTime":"2025-03-27 04:10","pubTimestamp":1743019828,"startTime":"0","endTime":"0","summary":"BRIEF-Rani Therapeutics Announces Preclinical Data Demonstrating Bioequivalence Of RT-114, A GLP-1/GLP-2 Dual Agonist (PG-102) Delivered Orally Via The RaniPill Capsule, To Subcutaneously Administered","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nFWN3Q90ZF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RANI"],"gpt_icon":0},{"id":"2522304953","title":"Rani Therapeutics Holdings Inc  expected to post a loss of 25 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2522304953","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522304953?lang=en_us&edition=fundamental","pubTime":"2025-03-27 04:07","pubTimestamp":1743019675,"startTime":"0","endTime":"0","summary":"Rani Therapeutics Holdings Inc  expected to post a loss of25cents a share - Earnings Preview Rani Therapeutics Holdings Inc RANI.OQ RANI.O is expected to show no change in quarterly revenue when it re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nL5N3Q9230:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RANI"],"gpt_icon":0},{"id":"2522581083","title":"Rani Therapeutics Announces Preclinical Data Demonstrating Bioequivalence of RT-114, a GLP-1/GLP-2 Dual Agonist (PG-102) Delivered Orally via the RaniPill® Capsule, to Subcutaneously Administered PG-102","url":"https://stock-news.laohu8.com/highlight/detail?id=2522581083","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522581083?lang=en_us&edition=fundamental","pubTime":"2025-03-27 04:05","pubTimestamp":1743019500,"startTime":"0","endTime":"0","summary":"-  RT-114 yielded a relative bioavailability of 111% compared to PG-102 delivered subcutaneously with comparable PK profiles, meeting the primary endpoint of demonstrating bioequivalence –。- Both groups demonstrated comparable weight loss with less variability observed with RT-114 compared to subcutaneous PG-102 –。- Phase 1 clinical trial of subcutaneous PG-102 demonstrated weight loss in obese patients, with an average reduction of 4.8% and up to 8.7% following five weeks of dosing -. - Data bolster expanding body of evidence of the RaniPill platform’s potential to facilitate oral delivery of multiple obesity treatments including previously announced semaglutide -. - Phase 1 clinical study for RT-114 for the treatment of obesity expected to initiate in mid- 2025 -. ProGen recently announced preliminary results of the repeat-dose portion  of its Phase 1 study where SC PG-102 demonstrated weight loss in obese subjects, with an average reduction of 4.8% and up to 8.7% following five week","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/rani-therapeutics-announces-preclinical-data-200500857.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RANI","LENZ","PG","GLP"],"gpt_icon":0},{"id":"2522583990","title":"Rani Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2522583990","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522583990?lang=en_us&edition=fundamental","pubTime":"2025-03-26 06:00","pubTimestamp":1742940000,"startTime":"0","endTime":"0","summary":"SAN JOSE, Calif., March 25, 2025  -- Rani Therapeutics Holdings, Inc.  , a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that it plans to release financial results for the fourth quarter and full year ended December 31, 2024 and provide a business update on Monday, March 31, 2025 after the close of trading. Rani’s management team will host a conference call and webcast beginning at 4:30 p.m. ET.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/rani-therapeutics-report-fourth-quarter-220000320.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RANI","LENZ","BK4139"],"gpt_icon":0},{"id":"2520889517","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2520889517","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520889517?lang=en_us&edition=fundamental","pubTime":"2025-03-17 18:00","pubTimestamp":1742205600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Bitcoin Depot Inc.                               4Q       .02   8:05 AM. ·IHS Hldg Ltd.                                    4Q       .01   6:00 AM","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STTK","OABI","ABSI","STNE","CAL","KOPN","BTM","PL","GLUE","ASO","CBUS","FLUX","IMTX","KLC","OSS","NOA","LPRO","FIVE","DMAC","CMC","SGMO","SCPH","LEN.B","INO","PHUN","BLTE","DERM","BCAB","NRXP","LAR","HYPR","LXEO","SIG","LVTX","SPRY","RANI","LQDA","DRI","MSIF","OPTN","RBOT","RWAY","AEVA","CELC","ANRO","SAIC","AUTL","CNTX"],"gpt_icon":1},{"id":"2519876572","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2519876572","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519876572?lang=en_us&edition=fundamental","pubTime":"2025-03-14 18:00","pubTimestamp":1741946400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Bitcoin Depot Inc.                               4Q       .02   8:05 AM. ·IHS Hldg Ltd.                                    4Q       .01   6:00 AM","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAPR","HTHT","TME","IFRX","LE","NKTX","IDN","LXEO","NRXP","GIS","GANX","CAL","INKT","PL","JILL","FDS","MRC","ERAS","ABSI","ANRO","LPRO","GOGO","RLYB","PRSO","LAR","DTIL","FDX","KOPN","SPRY","LQDA","TYRA","HROW","DTI","ACN","CNTX","AEVA","LVTX","DRI","RANI","STNE","MBRX","AUTL","HYPR","INSE","OSS","AMPX","MGNX"],"gpt_icon":1},{"id":"2516503645","title":"Analysts Offer Insights on Healthcare Companies: COMPASS Pathways (CMPS) and Rani Therapeutics Holdings (RANI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2516503645","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516503645?lang=en_us&edition=fundamental","pubTime":"2025-03-02 00:50","pubTimestamp":1740847832,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on COMPASS Pathways (CMPS – Research Report) and Rani T...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-compass-pathways-cmps-and-rani-therapeutics-holdings-rani?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-compass-pathways-cmps-and-rani-therapeutics-holdings-rani?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4139","CMPS","HCSG","BK4007","RANI","BK4539"],"gpt_icon":0},{"id":"2512516545","title":"RANI: Impressive Bioavailability for RT-116","url":"https://stock-news.laohu8.com/highlight/detail?id=2512516545","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512516545?lang=en_us&edition=fundamental","pubTime":"2025-02-18 17:24","pubTimestamp":1739870640,"startTime":"0","endTime":"0","summary":"On February 5th, Rani Therapeutics Holdings, Inc.  shared its preclinical readout from the RT-116 study demonstrating successful oral delivery of semaglutide using the RaniPill High Capacity  device compared to subcutaneous  injection. The study was conducted in eight canines to generate pharmacokinetic  and pharmacodynamic  data evaluating oral delivery of the glucagon-like peptide-1 receptor  agonist. In the press release, Rani updated stakeholders on the RT-114 program that is being developed with ProGen Co., targeting a start for the GLP-1/GLP-2 dual agonist Phase I study in 2025.A recent article in the Danish financial publication, Brsen, drew a connection between semaglutide’s sponsor, Novo Nordisk and Rani via a senior executive who previously served at the former and now acts as a Senior Strategic Advisor at the latter. The individual we are referring to is Jesper Hiland who highlighted several synergies between the RaniPill and future opportunities for the semaglutide brands O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/rani-impressive-bioavailability-rt-116-092400369.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4539","BK4181","LU1169590202.USD","BK4218","PK","LU1169589451.USD","PD","BK4007","RANI","BK4023"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":43,"code":"91000000","status":"200"}]}}